Singapore markets close in 5 hours 5 minutes

Cytogen, Inc. (217330.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
10,150.00-1,010.00 (-9.05%)
As of 12:35PM KST. Market open.
Currency in KRW

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-35.94%
S&P500 52-week change 328.04%
52-week high 319,330.00
52-week low 310,060.00
50-day moving average 313,136.20
200-day moving average 314,160.00

Share statistics

Avg vol (3-month) 383.33k
Avg vol (10-day) 370.28k
Shares outstanding 55.63M
Implied shares outstanding 6N/A
Float 810.27M
% held by insiders 139.70%
% held by institutions 10.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 328 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-355.59%

Management effectiveness

Return on assets (ttm)-12.74%
Return on equity (ttm)-53.44%

Income statement

Revenue (ttm)3.18B
Revenue per share (ttm)174.12
Quarterly revenue growth (yoy)67.00%
Gross profit (ttm)N/A
EBITDA -9.88B
Net income avi to common (ttm)-15.77B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)54.89B
Total cash per share (mrq)2,470.29
Total debt (mrq)17.58B
Total debt/equity (mrq)32.94%
Current ratio (mrq)5.21
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-7.59B
Levered free cash flow (ttm)-13.73B